Clinical trial
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical…
NCT00295789 · Haruhiko Fukuda, Other · Completed
Key facts
| NCT number | NCT00295789 |
|---|---|
| Title | Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3) |
| Official title | A Randomized Phase III Trial of Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Carboplatin in Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3) |
| Lead sponsor | Haruhiko Fukuda, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Uterine Cervical Neoplasms |
| Intervention type | Drug |
| Interventions | chemotherapy: Paclitaxel/Cisplatin, chemotherapy: Paclitaxel/Carboplatin |
| Enrollment | 253 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Feb 24, 2006 |
| Last update posted | Sep 22, 2016 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: